Camille Bedrosian named Amylyx CMO

Neurodegenerative disease company Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) hired Camille Bedrosian as CMO. Bedrosian was CMO at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Alexion Pharmaceuticals Inc. and Ariad Pharmaceuticals Inc. She succeeds Patrick Yeramian, who is retiring. 

Spyre Therapeutics Inc. (NASDAQ:SYRE), formerly known as Aeglea BioTherapeutics Inc., named Cameron Turtle as CEO and board member. Turtle, who joined the company as COO in June, was previously chief strategy officer at BridgeBio Pharma Inc. (NASDAQ:BBIO). ...